Synchron, which is developing a brain-computer interface that helps paralysis patients text, email, and shop online, raises $40M Series B led by Khosla Ventures (Andrea Park/FierceBiotech)

Andrea Park / FierceBiotech:Synchron, which is developing a brain-computer interface that helps paralysis patients text, email, and shop online, raises $40M Series B led by Khosla VenturesAfter years of focusing on all things artificial intelligence, the buzziest buzz in medtech now centers not on robots and algorithms
Click here to read full news..

guestpostbloggingwork

websitextra

,synchron series khosla venturesparkfiercebiotech ,synchron khosla venturesparkfiercebiotech ,series khosla venturesparkfiercebiotech

Related Post

Enhancing Quality with Nonconformance Management Software

Every industry aims to maintain high standards of quality and compliance....

Latest Post

Cream Lehenga Choli: A Subtle and Elegant Choice

When it comes to Indian ethnic wear, the Cream...